Lyophilized Meningococcal Polysaccharide Vaccine->aspalthic products

Join

Help

Changchun Changsheng Life Sciences Ltd.

	Recommended Results

Lyophilized Meningococcal Polysaccharide Vaccine

Category :

Chemicals->Chemical->aspalthic products

Lyophilized Meningococcal Polysaccharide Vaccine

Product Specification

Model No:	0.5ml/vial

Country	CN
Brand	WANXIN
Minimum Order	5000
Payment Term	L/C,T/T

Product Detail

Group ACYW135 meningococcal polysaccharide vaccine is a preparation of purified capsular polysaccharide antigens extracted from the cultures of Neisseria meningitidis group A, C, Y, W135 respectively and lyophilized after addition of an appropriate stabilizer. It is used to prevent epidemic cerebrospinal meningitis caused by Neisseria meningitidis group A, C, Y and W135.


 


The final product looks like a white crisp cake. It shall dissolve in the accompanying Phosphate buffered saline (PBS) immediately, and turn into a clear liquid after reconstitution. 
Active constituent: Neisseria meningitidis group ACYW135 capsular polysaccharides. 
Subsidiary materials: All the components of subsidiary materials approved shall be listed. 
Vaccine diluent: Sterile, pyrogen-free PBS. 
[Specifications] 
0.5 ml of reconstituted vaccine per container. 0.5 ml per single human dose, containing  200μg of meningococcal polysaccharide (50μg of each polysaccharide of group A,C,Y,W135). 
[Feature] 
Fill a gap in our country for the first time by developing 4-valent vaccine . 
Improve traditional purification technology to eliminate nucleic acid and protein. 
Improve WHO specifications and high harvest rate. Develop new type of stabilizer. Improve national quality standards. 



[Administration and dosage]


(1) Reconstitute the vaccine with the accompanying PBS as the stated value. Shake and inject immediately.


(2) The vaccine shall be injected s. c. at deltoid insertion area of the lateral upper arm.


(3) One single human dose of 0.5 ml vaccine is required. The immunization shall be carried out before the epidemic season of epidemic cerebrospinal meningitis.


[Adverse reactions]


Common adverse reactions:


(1) Pain, tenderness, mild or moderate erythema, swelling and infiltration at the injection site within 24 hours after Vaccination, which Can subside spontaneously within 2-3 days in most cases.


(2) Transient fever may occur after vaccination, most of which are mild, can be relieved spontaneously within l-2 days, and need no particular treatment. The recipients with moderate fever or the fever lasting for more than 48 hours may receive symptomatic treatment.


Rare adverse reactions:


(1) Severe fever: Symptomatic treatment shall be given to prevent febrile convulsion.


(2) Serious erythema and, swelling at the injection site or other complications: symptomatic treatment shall be given.


Extremely rare adverse reactions:


(1) Allergic rash: Rash may occur with 72 hours after vaccination. Antianaphylactic treatment should be given to the recipients with rash promptly.


(2) Anaphylactic shock: Anaphylactic shock may occur within one hour after vaccination.  Emergency treatment including injection with adrenaline shall be given promptly.


(3) Allergic purpura: Antianaphylactic treatment with corticosteroid should be given to the recipients with allergic purpura. Give anti-allergic treatment with cortical steroids. If the treatment is inappropriate or delayed,  purpura nephritis may be complicated.


(4) Angioneurotic edema and allergic neuritis may occur occasionally.


(5) Allergic exfoliative dermatitis cases have been reported occasionally.


[Contraindications]


(1) Subjects with known allergic reactions to any component of the vaccine.


(2) Subjects with acute diseases, severe chronic diseases, chronic diseases at stage of acute attack or fever.


(3) Subjects with encephalopathy, uncontrolled epilepsy,  and other progressive diseases of nervous system.


[Precautions]


(1) The vaccine should be administered with caution to the subjects with family or individual history of convulsion or those with chronic diseases, history of epilepsy,  allergic diathesis or nursing women.


(2) Do not use the vaccine if the container shows abnormalities, such as crack, illegible label, and turbidity after reconstitution


(3) Adrenaline should be available for first aid in case of severe anaphylactic reactions. The recipients shall be observed for at least 30 minutes on site after injection.


(4) Freezing of vaccine is forbidden.


[Storage]


Store and ship the product at 2-8℃, protected from light.


[Packaging]  


[Validity period] 24 months.

 
1.Group ACYW135                              
2.Group A+C                                       
3.prevent epidemic cerebrospinal meningitis                                                   

 


4.purified capsular polysaccharide antigens  
<img src="http://i.bosscdn.com/product/18/f2/13/d46381b9bd8edf65b150508726.png@watermark=2&color=I0ZGRkZGRg%3D%3D&type=ZHJvaWRzYW5zZmFsbGJhY2s%3D&size=22&p=9&t=80&text=Y3MtdmFjY2luZS5ib3NzZ29vLmNvbQ%3D%3D" title="-ACYW135" alt="-ACYW135" /> 
 



 
ccls-vaccine.com

More Products from this Supplier

Lyophilized Varicella Immunization Vaccine

Rabies Vaccine(Vero Cell) Injection

Hepatitis A (Live) Vaccine

Clinical Rabies Vaccine For Human Use


[ Back Products Catalog ]

Commerce Member:
Please log in your ID and password, we will later fill in relating info.

ID:

Password:

Remember my ID on this computer


	Complete this form below to send out your enquiries. All enquiries will be automatically sent to the company you want to develop.

	Subject
	Content	(Don't input Company Name, E-Mail, Phone Number, Fax Number, and URL)

Company Profile:

* Company Name

*E-mail

*Country

*Contact Person

URL

*Phone

- -

Fax

- -

*Postal code

*City

*Street Address

*Business Nature

Distributor Exporter Importer Manufacturer
Whole Sale Retailer Reseller Retrofitter User
Others, please specify:

*Security Code


Enter the security code.